Sanofi (SNY) Other Operating Expenses (2009 - 2026)
Sanofi (SNY) posted Other Operating Expenses of -$3.8 billion for Q3 2025, down 336.22% sequentially from -$869.9 million in Q1 2025, and down 247.97% YoY from $2.6 billion in Q3 2024.
Sanofi (SNY) Other Operating Expenses (2009 - 2026) Analysis & Trends
Sanofi has reported Other Operating Expenses for 12 years, with the latest figure at -$3.8 billion in Q3 2025.
- Quarterly Other Operating Expenses fell 247.97% year-over-year to -$3.8 billion in Q3 2025, while the trailing twelve-month figure through Jun 2026 was -$3.8 billion (up 16.3% YoY) and the FY2024 annual result came in at -$2.6 billion, up 3.93% from the prior year.
- Other Operating Expenses slipped to -$3.8 billion in Q3 2025 per SNY's latest filing, from -$869.9 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at -$656.2 million in Q1 2024 and troughed at -$3.8 billion in Q3 2025.
- A 3-year average of -$1.9 billion and a median of -$1.8 billion in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Operating Expenses climbed 3.41% in 2024, then tumbled 247.97% in 2025.
- Over 3 years, Other Operating Expenses stood at -$2.7 billion in 2023, then gained by 3.41% to -$2.6 billion in 2024, then tumbled by 47.47% to -$3.8 billion in 2025.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$3.8 billion, -$869.9 million, and -$2.6 billion for Q3 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 602.10 Mn |
| Mar 31, 2026 | 330.15 Mn |
| Dec 31, 2025 | 1.43 Bn |
| Sep 30, 2025 | -3.79 Bn |
| Mar 31, 2025 | -869.91 Mn |
| Dec 31, 2024 | -2.57 Bn |
| Sep 30, 2024 | -1.09 Bn |
| Mar 31, 2024 | -656.16 Mn |
| Dec 31, 2023 | -2.66 Bn |
| Dec 31, 2017 | -134.23 Mn |
| Dec 31, 2016 | -84.22 Mn |
| Sep 30, 2016 | -30.14 Mn |
| Jun 30, 2016 | -42.94 Mn |
| Mar 31, 2016 | -31.99 Mn |
| Dec 31, 2015 | 176.47 Mn |
| Sep 30, 2015 | 100.11 Mn |
| Jun 30, 2015 | 77.36 Mn |
| Mar 31, 2015 | 1.13 Mn |
| Dec 31, 2014 | -378.70 Mn |
| Sep 30, 2014 | -59.73 Mn |